In a groundbreaking development, a small Welsh company, Afon Technology, has achieved a significant milestone by successfully creating the world’s first non-invasive and wearable glucose sensor. This remarkable device, which takes the form of a watch, can accurately measure blood sugar levels without the need for skin penetration, according to the latest research findings.
The results of a clinical study, soon to be published in the prestigious Journal of Diabetes Science and Technology, have confirmed the efficacy of Afon Technology’s innovative device. The study, conducted in Germany, involved a team of researchers who conducted multiple tests using the Afon device. The promising outcomes of this trial indicate that the lives of individuals living with diabetes are about to undergo a transformative change.
Sabih Chaudhry, the CEO of Afon Technology, expressed enthusiasm about the device’s potential impact on people with diabetes, stating, “Our device will be a game-changer for those living with diabetes, as it provides a pain-free and convenient way to monitor their blood glucose levels.” This cutting-edge invention eliminates the need for invasive injections, offering a revolutionary solution to a long-standing challenge in diabetes management.
Chaudhry further emphasized the significance of this achievement, highlighting the power of innovation and the boundless possibilities that arise from pushing the boundaries of what is considered feasible. This success is a testament to the relentless dedication and hard work of Afon Technology’s team, who have brought this remarkable device to fruition. The company eagerly anticipates the positive impact it will have on the health and well-being of countless individuals worldwide.
The device’s design includes an alert system to notify users of high and low glucose levels, enabling timely interventions. Additionally, it offers personalized health trend monitoring, facilitating a comprehensive approach to diabetes management.
Notably, industry giants such as Apple, Samsung, and Google have long been rumored to be pursuing non-invasive blood glucose monitoring technology. However, Afon Technology has taken a significant leap forward in realizing this goal, positioning itself as a frontrunner in the race to develop a reliable and non-invasive solution.
Founded in 2015 and headquartered in Wales, Afon Technology has received several grants for its pioneering work in this field. The company’s recent achievement includes an Accelerator Grant of €2.4 million from the European Innovation Council, which further validates the significance and potential impact of their ground-breaking technology.
In conclusion, Afon Technology’s development of the world’s first non-invasive and wearable glucose sensor represents a monumental breakthrough for individuals living with diabetes. By providing a pain-free and convenient method to monitor blood glucose levels, this innovative device promises to revolutionize diabetes management. Afon Technology’s dedication to pushing boundaries and relentless pursuit of innovation have made this game-changing solution possible, paving the way for enhanced health and well-being across the globe.
Read the study here.